Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00134602 · ClinicalTrials.gov registry record · NA

Pediatric Impact: Promoting Adherence to Medications Among HIV-infected Children

A NA study of HIV Infections, sponsored by Centers for Disease Control and Prevention.

Completed
Registry status
NA
Development phase
180
Enrollment target
3
Study locations

NCT00134602 is a NA study of HIV Infections that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 180 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (60% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00134602, a NA study of HIV Infections, has completed, sponsored by Centers for Disease Control and Prevention.

COMPLETED
Registry status
NA
Development phase
180 participants
Enrollment target
3
Study locations

Study Summary

The purpose of the study is to develop and evaluate an intervention to promote adherence to HIV medications among children 5-12 years of age. It compares changes in antiretroviral (ARV) adherence between the EIG (enhanced intervention group) and an MIG (minimal intervention group) from baseline to 4 months post-intervention. Secondary outcomes include examining whether improvement in adherence to a medication regimen is associated with improved health outcomes (i.e., viral load, CD4 counts, etc.); identifying and evaluating predictors and/or mediators of adherence; studying the feasibility of electronic recording in measuring adherence in an HIV-infected pediatric population; and evaluating the relationship between the amount of intervention received (i.e., number of hours/number of sessions) and changes in adherence.

Conditions Studied

HIV Infections

Interventions

  • BEHAVIORAL Needs assessment followed by tailored intervention

Study Locations (3)

District of Columbia

  • Children's National Medical Center - Washington D.C.
  • Howard University Hospital, Department of Pediatrics - Washington D.C.

New York

  • Jacobi Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2003-04
Est. Completion 2008-10
Phase NA

Sponsor

Centers for Disease Control and Prevention

139 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00134602

The ClinicalTrials.gov registry entry for NCT00134602 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (60% lower). The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Needs assessment followed by tailored intervention is the first listed.

NCT00134602 reports 3 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, New York.

Frequently Asked Questions

What is clinical trial NCT00134602 about?

NCT00134602 is a clinical study titled "Pediatric Impact: Promoting Adherence to Medications Among HIV-infected Children". The purpose of the study is to develop and evaluate an intervention to promote adherence to HIV medications among children 5-12 years of age. It compares changes in antiretroviral (ARV) adherence between the EIG (enhanced intervention group) and an MIG (minimal intervention group) from baseline to 4...

What is the current status of trial NCT00134602?

This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2003-04. Estimated completion is 2008-10.

What conditions does trial NCT00134602 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00134602?

The interventions under investigation include: Needs assessment followed by tailored intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00134602?

This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00134602 being conducted?

This trial has 3 study locations across District of Columbia, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.